Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
EB-DNK101 dual-targeting CAR-NK cells (MSLN + MUC1)
/
mega-study
EB-DNK101 dual-targeting CAR-NK cells (MSLN + MUC1)